Diamyd Medical AB (publ)
DYMDF
$0.73
$0.000.00%
OTC PK
| 05/31/2025 | 02/28/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | 225.00% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | 225.00% | |||
| Cost of Revenue | -1.63% | -4.56% | |||
| Gross Profit | -6.84% | 10.03% | |||
| SG&A Expenses | 28.54% | -15.43% | |||
| Depreciation & Amortization | 17.97% | -1.04% | |||
| Other Operating Expenses | -14.71% | -154.72% | |||
| Total Operating Expenses | 17.03% | 2.35% | |||
| Operating Income | -17.25% | -2.21% | |||
| Income Before Tax | -8.87% | -19.13% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -8.87% | -19.13% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -8.87% | -19.13% | |||
| EBIT | -17.25% | -2.21% | |||
| EBITDA | -17.51% | -2.08% | |||
| EPS Basic | -7.12% | -16.96% | |||
| Normalized Basic EPS | -6.10% | 2.38% | |||
| EPS Diluted | -7.12% | -16.96% | |||
| Normalized Diluted EPS | -6.10% | 2.38% | |||
| Average Basic Shares Outstanding | 1.74% | 1.73% | |||
| Average Diluted Shares Outstanding | 1.74% | 1.73% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||